HHS Extends Liability Shield to Antivirals Used for H1N1

The Department of Health and Human Services (HHS) recently provided a shield against damage claims related to the use of the antiviral drugs oseltamivir (Tamiflu) and zanamivir (Relenza) in the current H1N1 influenza pandemic.

Read more...